Skip to main content
Clinical Trials/NCT02912273
NCT02912273
Completed
Not Applicable

Optimizing Fall-risk Prediction in Older Adults With Cancer

Washington University School of Medicine1 site in 1 country227 target enrollmentOctober 12, 2016
ConditionsCancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Washington University School of Medicine
Enrollment
227
Locations
1
Primary Endpoint
Number of falls
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.

Registry
clinicaltrials.gov
Start Date
October 12, 2016
End Date
January 9, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Receiving systemic cancer therapy, including conventional chemotherapy, novel/targeted agents or hormonal agents (e.g. anti-estrogen or anti-androgen) OR will begin systemic therapy within the next 4 weeks.
  • Estimated life expectancy \>1 year
  • Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
  • Able to understand and willing to sign an IRB-approved written informed consent document

Exclusion Criteria

  • Unable to read and understand English

Outcomes

Primary Outcomes

Number of falls

Time Frame: Up to 6 months

-The Prevention of Falls Network Europe (PROFANE) Consensus Group guidelines will be used

Secondary Outcomes

  • Overall survival(Up to 6 months)
  • Time to fall event(Up to 6 months)
  • Number of falls that were considered injurious falls(Up to 6 months)
  • Fear of falling as Measured by the Falls Efficacy Scale-International(Up to 6 months)

Study Sites (1)

Loading locations...

Similar Trials